JP2018532748A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018532748A5 JP2018532748A5 JP2018521987A JP2018521987A JP2018532748A5 JP 2018532748 A5 JP2018532748 A5 JP 2018532748A5 JP 2018521987 A JP2018521987 A JP 2018521987A JP 2018521987 A JP2018521987 A JP 2018521987A JP 2018532748 A5 JP2018532748 A5 JP 2018532748A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- composition
- cathepsin
- amyloidosis
- enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562248713P | 2015-10-30 | 2015-10-30 | |
| US62/248,713 | 2015-10-30 | ||
| PCT/US2016/059587 WO2017075540A1 (en) | 2015-10-30 | 2016-10-28 | Methods and compositions for the treatment of amyloidosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018532748A JP2018532748A (ja) | 2018-11-08 |
| JP2018532748A5 true JP2018532748A5 (enExample) | 2019-12-05 |
Family
ID=58631207
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018521987A Pending JP2018532748A (ja) | 2015-10-30 | 2016-10-28 | アミロイドーシス治療のための方法及び組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (4) | US20170119861A1 (enExample) |
| EP (1) | EP3368048A4 (enExample) |
| JP (1) | JP2018532748A (enExample) |
| CN (1) | CN108367018A (enExample) |
| AR (1) | AR106538A1 (enExample) |
| AU (1) | AU2016343812A1 (enExample) |
| BR (1) | BR112018008839A8 (enExample) |
| CA (1) | CA3002410A1 (enExample) |
| MX (1) | MX2018005352A (enExample) |
| TW (1) | TW201729833A (enExample) |
| WO (1) | WO2017075540A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12053510B2 (en) | 2018-05-01 | 2024-08-06 | Orfoneuro Aps | Treatment of neuronal ceroid lipofuscinosis |
| PL3810128T3 (pl) | 2018-06-19 | 2023-01-30 | Universidad Pablo De Olavide | Kompozycje do leczenia i/lub zapobiegania chorobom związanym z agregacją białek |
| CN109701040B (zh) * | 2019-03-08 | 2021-04-06 | 昆明医科大学第一附属医院 | 一种用于诊治mtc的纳米pamam靶向多肽放射性核素制剂及制备方法 |
| WO2020214033A1 (en) * | 2019-04-17 | 2020-10-22 | Erasmus University Medical Center Rotterdam | Papain-like cysteine peptidase medicaments and uses thereof |
| US20220364101A1 (en) * | 2019-07-05 | 2022-11-17 | Tokushima University | Modified neuraminidase |
| WO2024131237A1 (en) * | 2022-12-21 | 2024-06-27 | Hwu Wuh Liang | Recombinant viral vector, recombinant adeno-associated virus comprising the same, and uses thereof in treating sialidosis |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000050886A (ja) * | 1998-06-05 | 2000-02-22 | Fuji Chemical Industries Ltd | 新規なヒトカテプシンｌ２タンパク質及びそれをコ―ドする遺伝子並びにそれらの利用 |
| US20040110669A1 (en) * | 2001-05-16 | 2004-06-10 | Kakkis Emil D. | Destruction of prions using vibriolysin or variants thereof |
| US8137666B2 (en) * | 2008-11-22 | 2012-03-20 | Academia Sinica | Nattokinase for degrading and reducing amyloid fibrils—associated with alzheimer's disease, prion diseases and other amyloidoses |
| JP5665065B2 (ja) * | 2011-04-28 | 2015-02-04 | 国立大学法人大阪大学 | リソソーム病治療用医薬組成物 |
| SI2751279T1 (en) * | 2011-08-31 | 2018-01-31 | St. Jude Children's Research Hospital | Procedures and compositions for detecting the level of activity of lysosomal exocytosis and application procedures |
| JP6219934B2 (ja) * | 2012-05-22 | 2017-10-25 | バーグ エルエルシー | 薬物誘発毒性マーカーを同定するための照合による細胞に基づくアッセイ |
| JP2014144933A (ja) * | 2013-01-29 | 2014-08-14 | Kwangju Inst Of Science & Technol | アミロイドβの除去 |
-
2016
- 2016-10-28 JP JP2018521987A patent/JP2018532748A/ja active Pending
- 2016-10-28 CA CA3002410A patent/CA3002410A1/en active Pending
- 2016-10-28 EP EP16861010.3A patent/EP3368048A4/en not_active Withdrawn
- 2016-10-28 BR BR112018008839A patent/BR112018008839A8/pt active Search and Examination
- 2016-10-28 AU AU2016343812A patent/AU2016343812A1/en not_active Abandoned
- 2016-10-28 MX MX2018005352A patent/MX2018005352A/es unknown
- 2016-10-28 US US15/338,242 patent/US20170119861A1/en not_active Abandoned
- 2016-10-28 CN CN201680072193.9A patent/CN108367018A/zh active Pending
- 2016-10-28 WO PCT/US2016/059587 patent/WO2017075540A1/en not_active Ceased
- 2016-10-31 TW TW105135250A patent/TW201729833A/zh unknown
- 2016-10-31 AR ARP160103322A patent/AR106538A1/es not_active Application Discontinuation
-
2018
- 2018-12-19 US US16/226,092 patent/US20190183985A1/en not_active Abandoned
-
2020
- 2020-10-08 US US17/065,836 patent/US20210228694A1/en not_active Abandoned
-
2022
- 2022-09-06 US US17/930,014 patent/US20230127775A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018532748A5 (enExample) | ||
| Tammaro et al. | Metabolic flexibility and innate immunity in renal ischemia reperfusion injury: the fine balance between adaptive repair and tissue degeneration | |
| Williams et al. | Aggregate‐prone proteins are cleared from the cytosol by autophagy: therapeutic implications | |
| ZA202202410B (en) | Rna particles comprising polysarcosine | |
| SI2999785T1 (en) | SERPINA1 IRNA assemblies and procedures for their use | |
| WO2011149964A3 (en) | Methods for treating or preventing vascular graft failure | |
| JP2011103891A5 (enExample) | ||
| MX2012004343A (es) | Metodos para el tratamiento de la coagulacion intravascular diseminada mediante la inhibicion de la activacion del complemento dependiente de la masp-2. | |
| EP2808029A3 (en) | Combination therapies using cyclosporine and aromatic cationic peptides | |
| HRP20171909T1 (hr) | Postupci i sastavi za otkrivanje razine djelovanja lizosomalne eksocitoze i načini njihove uporabe | |
| RU2016113055A (ru) | Композиция для лечения и профилактики доброкачественной гиперплазии простаты | |
| JP2018516944A5 (enExample) | ||
| UA100127C2 (ru) | Пептид cdh3 и лекарственное средство, содержащее его | |
| WO2018155813A3 (ko) | 엔테로코쿠스 패슘에 대하여 용균력을 가지는 신규한 항균단백질 efal-2 | |
| JP2012503674A5 (enExample) | ||
| AR106538A1 (es) | Métodos y composiciones para el tratamiento de la amiloidosis | |
| CA2646589C (en) | Inhibition of tumour growth | |
| BRPI1014631A2 (pt) | peptídeos e seus usos. | |
| UA112752C2 (uk) | Лікарський засіб та метод блокування утворення або посилення знищення білка p24 | |
| JP6169607B2 (ja) | 抗腫瘍アジュバント療法 | |
| CA2549185A1 (en) | Peptide inhibiting angiotensin converting enzyme | |
| AU2009292959B2 (en) | Methods, systems, and compositions for calpain inhibition | |
| CA2634902A1 (en) | Anticancer agent comprising a peptide | |
| Nickavar et al. | Assesment, treatment and prevention of atypical hemolytic uremic syndrome | |
| KR101626526B1 (ko) | ｈＲｈｅｂ를 유효성분으로 포함하는 허혈성 뇌질환의 예방 또는 치료용 조성물 |